Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Implant Sciences receives $5 million private financing:

This article was originally published in Clinica

Executive Summary

Implant Sciences has completed a $5m private placement of common stock with four institutional investors. The Wakefield, Massachusetts company plans to use a portion of the proceeds for an accretive acquisition "which is currently under preliminary evaluation". Implant Sciences' product portfolio includes radioactive seeds for cancer treatment and coating technologies for medical devices, of which one is designed to modify the surface characteristics of orthopaedic joint implants so as to reduce polyethylene wear and prolong the implant's life.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058801

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel